BIODESIX, INC. (BDSX) Net margin 2019–2025
BIODESIX, INC. (BDSX) net profit margin by fiscal year — reported net income divided by reported revenue.
-39.8%FY2025 · since FY2019: -125.1% → -39.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -39.8% | +20.3 pp |
| FY2024 | -60.2% | +46.0 pp |
| FY2023 | -106.2% | +65.0 pp |
| FY2022 | -171.3% | -92.1 pp |
| FY2021 | -79.2% | +64.5 pp |
| FY2020 | -143.7% | -18.5 pp |
| FY2019 | -125.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Gross profitBDSX Gross marginBDSX Operating incomeBDSX Operating marginBDSX Operating cash flowBDSX Free cash flowBDSX Capital expendituresBDSX Return on equityBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Total liabilitiesBDSX Shareholders’ equityBDSX overview →